IRISIN-RELATED CANCER TREATMENTS
- 专利权人:
- STC.UNM
- 发明人:
- Kristina Trujillo,Nicholas Patrick Gannon,Roger Alan Vaughan
- 申请号：
- US15528348
- 公开号：
- US20170312339A1
- 申请日:
- 2015.11.18
- 申请国别(地区):
- US
- 年份:
- 2017
- 代理人:
- 摘要：
- In one embodiment, the invention provides methods of treating or preventing cancer, in particular aspects breast and/or prostate cancer, by administering to a subject in need thereof a therapeutically-effective amount of irisin and, optionally, one or more adjuvant therapies (e.g. synergistic co-administration of an additional anti-cancer agent or chemotherapy). Related pharmaceutical compositions, assays and kits are also provided.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- COMBINATION THERAPY FOR TREATING CANCER AND DIANOSTIC ASSAYS FOR USE THEREIN
- COMBINATION THERAPY FOR TREATING CANCER AND DIANOSTIC ASSAYS FOR USE THEREIN
- microRNAs in therapy and diagnostic of cancer
- Antibody or fragment thereof which specifically binds a Human variant of csf-1r, Pharmaceutical composition containing same and their use for the manufacture of a Medicament used for treating Cancer and Method for determining whether a subject is a candidate for Cancer Treatment based and
- "method for treating hyperproliferative dysfunction, pharmaceutical composition, use of a therapeutic combination in the manufacture of a medicament for treating cancer, article of manufacture for treating a hyperproliferative dysfunction, method for determining compounds to be used in combination for the treatment of cancer". cancer treatment and method for determining a therapeutic combination to be used for cancer treatment "
